Supplementary Methods, Figure Legends, Tables S1 - S4 from An Acquired &lt;i&gt;HER2&lt;/i&gt; &lt;sup&gt;T798I&lt;/sup&gt; Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant–Driven Breast Cancer